Form 6-K COMPUGEN LTD For: May 18

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2026

Commission File Number 000-30902

 

COMPUGEN LTD.

(Translation of registrant’s name into English)

 

26 Harokmim Street

Holon 5885849, Israel

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F ☒  Form 40-F ☐

Compugen Ltd.

 

On May 18, 2026, Compugen Ltd. (the “Company”) issued a press release reporting the Company’s first quarter 2026 results (the “Press Release”), a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K.

 

With the exception of the quotes attributable to Eran Ophir, Ph.D., information contained in the Press Release is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, File No. 333-270985.

 

Exhibit Number	Description of Exhibit
99.1	Press Release dated May 18, 2026 – “Compugen Reports First Quarter 2026 Results”

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	COMPUGEN LTD.
Date: May 18, 2026	By:	/s/ Eran Ben Dor
		Eran Ben Dor General Counsel

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
• MarketAnywhere Emerges as the Best Flyer Distribution Service in the USA
• Dr. Ranjan Rajbanshi Scholarship Opens Applications for Future Healthcare Professionals Nationwide